Recurrent Childhood Acute Lymphoblastic Leukemia Terminated Phase 1 Trials for DB00541 (Vincristine)

IndicationStatusPhase
DBCOND0028597 (Recurrent Childhood Acute Lymphoblastic Leukemia)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00933985Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or LeukemiaTreatment